BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1617088)

  • 1. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(1):95-113. PubMed ID: 1617088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses, interfacial active properties and toxicity of new perfluoroalkylated surfactants.
    Meinert H; Reuter P; Mader J; Haidmann L; Northoff H
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(1):115-24. PubMed ID: 1617081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of D-glucose 3- and 6-[2-(perfluoroalkyl)ethyl] phosphates: a new type of anionic surfactant for biomedical use.
    Milius A; Greiner J; Riess JG
    Carbohydr Res; 1992 May; 229(2):323-36. PubMed ID: 1394289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatible surfactants for water-in-fluorocarbon emulsions.
    Holtze C; Rowat AC; Agresti JJ; Hutchison JB; Angilè FE; Schmitz CH; Köster S; Duan H; Humphry KJ; Scanga RA; Johnson JS; Pisignano D; Weitz DA
    Lab Chip; 2008 Oct; 8(10):1632-9. PubMed ID: 18813384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroalkylated polyethylene glycol as potential surfactant for perfluorocarbon emulsion.
    Peng CA; Hsu YC
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Nov; 29(6):483-92. PubMed ID: 11795633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J; Reichelt H
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions.
    Thomas SR; Pratt RG; Millard RW; Samaratunga RC; Shiferaw Y; Clark LC; Hoffmann RE
    J Magn Reson Imaging; 1994; 4(4):631-5. PubMed ID: 7949694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorocarbon-based oxygen carriers: review of products and trials.
    Castro CI; Briceno JC
    Artif Organs; 2010 Aug; 34(8):622-34. PubMed ID: 20698841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toward a second generation of fluorocarbon emulsions. Methodologies: synthesis of fluorocarbons, formulation, preparation and control of emulsions].
    Leblanc M
    Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):465-83. PubMed ID: 3296111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeric THAM-derived perfluoroalkylated surfactants for fluorocarbon emulsions.
    Riess JG; Pavia AA; Pucci B; Zarif L
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):843-4. PubMed ID: 1391520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-Responsive Gene Delivery from Perfluorocarbon Nanoemulsions through Cleavable Poly(2-oxazoline) Surfactants.
    Estabrook DA; Day RA; Sletten EM
    Angew Chem Int Ed Engl; 2021 Aug; 60(32):17362-17367. PubMed ID: 33930255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of fluorocarbons and surfactants for in vivo applications. New perfluoroalkylated polyhydroxylated surfactants.
    Riess JG; Arlen C; Greiner J; Le Blanc M; Manfredi A; Pace S; Varescon C; Zarif L
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):421-30. PubMed ID: 3052646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of perfluorocarbon emulsions and their compatibility with blood serum.
    Kuznetsova IN
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):181-9. PubMed ID: 9564436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The toxicity of surface-active substances for emulsifying perfluorocarbon compounds as components of blood substitute preparations].
    Draffehn J; Reichelt H
    Pharmazie; 1991 Apr; 46(4):271-2. PubMed ID: 1886917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Study of Perfluorocarbon Nanoemulsions Stabilized by Polymer Amphiphiles.
    Day RA; Estabrook DA; Wu C; Chapman JO; Togle AJ; Sletten EM
    ACS Appl Mater Interfaces; 2020 Sep; 12(35):38887-38898. PubMed ID: 32706233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate- and related polyol-derived fluorosurfactants: an update.
    Riess JG; Greiner J
    Carbohydr Res; 2000 Jul; 327(1-2):147-68. PubMed ID: 10968680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.